1. In Vitro and In Vivo Evaluation of the Antischistosomal Activity of Polygodial and 9-Deoxymuzigadial Isolated from Drimys brasiliensis Branches.
- Author
-
Umehara E, Cajas RA, Conceição GB, Antar GM, Andricopulo AD, Moraes J, and Lago JHG
- Subjects
- Animals, Mice, Chlorocebus aethiops, Female, Male, Vero Cells, Polycyclic Sesquiterpenes pharmacology, Polycyclic Sesquiterpenes chemistry, Polycyclic Sesquiterpenes isolation & purification, Schistosomiasis mansoni drug therapy, Schistosomiasis mansoni parasitology, Schistosomicides pharmacology, Schistosomicides chemistry, Schistosomicides isolation & purification, Schistosoma mansoni drug effects, Sesquiterpenes pharmacology, Sesquiterpenes chemistry, Sesquiterpenes isolation & purification, Plant Extracts pharmacology, Plant Extracts chemistry, Drimys chemistry
- Abstract
In the present study, the hexane extract from branches of Drimys brasiliensis (Winteraceae) displayed potent activity against Schistosoma mansoni parasites (100% mortality of the worms at 200 μg/mL). Bioactivity-guided fractionation afforded, in addition to the previously reported bioactive sesquiterpene 3,6-epidioxy-bisabola-1,10-diene, two chemically related drimane sesquiterpenes-polygodial ( 1 ) and 9-deoxymuzigadial ( 2 ). The anti- S. mansoni effects for compounds 1 and 2 were determined in vitro, with compound 1 demonstrating significant potency (EC
50 value of 10 μM for both male and female worms), while 2 was inactive. Cytotoxicity assays against Vero cells revealed no toxicity for either compound (CC50 > 200 μM). Additionally, an in silico analysis was conducted using the SwissADME platform for 1 , revealing that this natural sesquiterpene exhibited adherence to several ADME parameters and no PAINS violations. Finally, in vivo studies with S. mansoni -infected mice treated with compound 1 demonstrated a 44.0% reduction in worm burden, accompanied by decreases in egg production of 71.8% in feces and 69.5% in intestines. These findings highlight the potential of polygodial ( 1 ) as a promising prototype for schistosomiasis treatment.- Published
- 2025
- Full Text
- View/download PDF